Non-diabetic Overweight or Obese

2

Review clinical trials related to Non-diabetic Overweight or Obese. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of BGM0504 Tablets in Healthy and Non-diabetic Overweight or Obese Chinese Subjects

A Randomized, Double-Blind, Placebo-Controlled, Single/Multiple-dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BGM0504 Tablets Orally Administered in Healthy and Non-diabetic Overweight or Obese Chinese Subjects.

Participants needed: 75
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: BrightGene Bio-Medical Technology Co., Ltd.Updated: Nov 20, 2025Locations: 1
Eligibility criteria

Between the ages of 18 and 65 years (inclusive) at the time of screening , healt... [+5]

Those with a history of severe drug allergies (especially those with known or su... [+15]

Status: Recruiting

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

This is a Phase 1, single-center, randomized, placebo-controlled, ascending dose study. The study will evaluate the pharmacokinetics (PK), pharmacodynamic (PD), preliminary efficacy, safety and tolerability of BGM0504 following daily oral administrations in non-diabetic overweight or obese adult subjects.

Participants needed: 80
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: BrightGene Bio-Medical Technology Co., Ltd.Updated: Sep 19, 2025Locations: 1
Eligibility criteria

Between ≥ 30.0 kg/m2 and ≤ 40.0 kg/m2 (obese); OR [+3]

Have allergic predisposition (allergic to 3 or more foods or drugs), or are alle... [+5]